Dermatology Cream Franchise in Ahmedabad

Antifungal Combination Cream Supplier in Mumbai

Skin Infection Treatment Cream Distributor in Delhi

Dermatology Product Manufacturer in Bangalore

Antibacterial Antifungal Cream Stockist in Hyderabad
Dermatology Medicine Exporter in Chandigarh

Home/Products /ofloxacin-0-point-75-w-w-ornidazole-2-w-w-itraconazole-1-w-w-clobetasol-0-point-05-w-w-cream

About the Product

Description


Ofloxacin + Ornidazole + Itraconazole + Clobetasol Cream is indicated for the management of mixed skin infections involving bacterial, fungal, and inflammatory components, commonly seen in dermatological conditions with redness and itching.

Ofloxacin provides broad-spectrum antibacterial coverage, ornidazole targets anaerobic microorganisms, itraconazole acts as a potent antifungal agent, and clobetasol helps control severe inflammation, itching, and erythema.

This combination is commonly prescribed in infected dermatitis, fungal infections with secondary bacterial involvement, eczema with infection, and inflammatory dermatoses, where multi-action therapy ensures faster symptom relief.

With strong therapeutic coverage, visible clinical results, and wide dermatology acceptance, this formulation supports repeat demand, builds prescriber confidence, and helps expand customer reach through effective management of common and recurrent skin infections.

Common side effects may include mild burning sensation, itching, redness, dryness, or irritation at the application site. Prolonged use may cause skin thinning, discoloration, or steroid-related effects.

Diziderm IT Cream is indicated for the treatment of fungal skin infections with secondary bacterial involvement, including dermatophytosis, candidiasis, tinea infections, infected eczema, and inflammatory dermatoses as advised by a healthcare professional.

For external use only. Apply a thin layer to the affected area as prescribed. Avoid prolonged use, especially on the face, groin, or broken skin. Discontinue use and consult a doctor if irritation, worsening of symptoms, or adverse reactions occur.

Store below 25°C in a cool, dry place. Protect from direct sunlight. Keep the tube tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ofloxacin 0.75% w/w + Ornidazole 2% w/w + Itraconazole 1% w/w + Clobetasol Propionate 0.05% w/w Cream in the PCD pharma franchise market?

Ofloxacin 0.75% w/w + Ornidazole 2% w/w + Itraconazole 1% w/w + Clobetasol Propionate 0.05% w/w Cream has strong demand in the dermatology and skin care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on dermatology portfolios.

Why should medical distributors include Ofloxacin + Ornidazole + Itraconazole + Clobetasol Cream in their product range?

Medical distributors and agencies can benefit from consistent demand for dermatological conditions requiring antimicrobial and anti-inflammatory management under medical supervision. Ofloxacin 0.75% w/w is a broad-spectrum antibacterial agent effective against susceptible bacteria Ornidazole 2% w/w provides activity against certain anaerobic microorganisms and protozoa Itraconazole 1% w/w is an antifungal agent used in the management of susceptible fungal skin infections Clobetasol Propionate 0.05% w/w is a potent corticosteroid that helps reduce inflammation, redness, itching, and irritation Commonly prescribed for mixed skin infections and inflammatory dermatological conditions where combined antimicrobial and anti-inflammatory therapy is considered appropriate by healthcare professionals Cream formulation allows localized application directly to the affected area Widely prescribed by dermatologists and healthcare professionals This strengthens a comprehensive dermatology and skin care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ofloxacin 0.75% w/w + Ornidazole 2% w/w + Itraconazole 1% w/w + Clobetasol Propionate 0.05% w/w Cream with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in the dermatology segment, repeat prescriptions, reliable supply chain support, growing market opportunities, and attractive margins in skin care products.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.